Innovative migraine management includes CGRP monoclonal antibodies, a promising class of medications designed to prevent migraines. Neuromodulation devices like the Cefaly and gammaCore offer non-pharmacological relief. Emerging research explores genetics, precision medicine, and novel therapies, offering hope for more effective and personalized migraine treatments in the future.